• Positive Test Boosts Sanofi (France) (SAN.PA) MS Drug Hopes More...

• Veloxis Pharmaceuticals A/S (VELO) to Present Results from a Patient Subgroup Analysis of Once-Daily LCP-Tacro™ in Stable African-American Kidney Transplant Patients at American Transplant Congress More...

• Talon Therapeutics, Inc. (TLON.OB) Announces Enrollment and Dosing of the First Patient in the Phase 3 Confirmatory Study of Marqibo(R) in Adult Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (HALLMARQ Study) More...

• UCB, Inc. (UCBJF.PK) to Showcase Broad Immunology Portfolio at EULAR2012 More...

• Johnson & Johnson (JNJ) Seeks Approval of Diabetes Pill More...

• Can a Decade of Dark Chocolate Protect Your Heart? Monash University Study More...

• Paralysed Rats Walk Again in Swiss Lab Study, Ecole Polytechnique Federale de Lausanne Reveals More...

• "Key Step" Closer to Universal Flu Vaccine, Emory University Study More...

• Autism May Diminish Belief in God, University of British Columbia Study More...

• Antioxidant Beta-Carotene Use Safe During Radiation Treatment for Prostate Cancer, Dana-Farber Cancer Institute Study More...

• Kythera Biopharmaceuticals Receives Notice of Allowance from U.S. Patent Office for Composition Claims Covering ATX-101 Active Ingredient More...

• NovaBay Pharmaceuticals, Inc. Strengthens Global Aganocide(R) Patent Estate With Seven New Patents More...

• Arcadia Biosciences, Inc. Receives Second Key Chinese Patent for Nitrogen Use Efficiency Technology More...

• UK's National Institute for Clinical Excellence (NICE) Recommends Johnson & Johnson (JNJ)'s Xarelto for Treating Blood Clots More...

• Marina Biotech, Inc. Runs Out of Cash, Axes 90 Pct. of Staff More...

• Sanofi (France) (SAN.PA) Aims to be Pharma's Top R&D Organization More...

• NicOx SA (COX.PA) Board Decides Not to Exercise its Option to Acquire the Remaining Shares of Altacor More...

• Forest Laboratories, Inc. (FRX) Coughs Up $25 Million for Nabriva Therapeutics's Phase II Antibacterial, Right to Take Over Company More...

• Boehringer Ingelheim Pharmaceuticals, Inc. and CancerCare® Launch My Cancer Circle™ Online Tool for Cancer Caregivers More...

• ACM Global Central Laboratory Appoints Mark Engelhartas Chief Commercial Officer More...

• Changes in Siegfried Management More...

• Human Genome Sciences, Inc. (HGSI) Takeover Defense Survives Court Test More...

• PharmAthene, Inc. Release: Delaware Chancery Court Issues Final Order and Judgment Upholding Its Favorable Ruling More...